Anna Ravnefjord

Senior Consultant
M Sci Bio

anna.ravnefjord@regsmart.se +46 (0)767-22 48 33

Anna is a senior pharmaceutical development professional with a background in both early drug development and regulatory affairs. She began her career as a research scientist working on early pre-clinical projects in big pharma, contributing to innovative drug discovery programs across multiple therapeutic areas and modalities.

More about Anna

Over the years, Anna has developed deep expertise in Regulatory Affairs across the full development lifecycle—from early target discovery and clinical development to global registrations and lifecycle management. She has a particular passion for shaping regulatory strategies that support clinical development programs and help innovative therapies progress efficiently while meeting evolving regulatory expectations.

Having worked across small and mid-sized biotech companies as well as large global pharmaceutical organizations, Anna brings a flexible and pragmatic perspective to drug development.